PRECLINICAL STUDIES OF THE SPECIFIC ACTIVITY OF THE NEW ANTITUBERCULOSIS DRUG THIOZONIDE
In vitro and in vivo preclinical studies of the antituberculosis activity of thiozonide designed at the ZAO “Farn-Sintez” (Moscow) were conducted at the Central Research of Tuberculosis, Russian Academy of Medical Sciences. The in vitro study indicated that thiozonide exerted an antimycobacterial ef...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
NEW TERRA Publishing House
2014-06-01
|
Series: | Tuberkulez i Bolezni Lëgkih |
Subjects: | |
Online Access: | https://www.tibl-journal.com/jour/article/view/90 |